STAAR Surgical (STAA) Tops Q1 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to STAAR Surgical (STAA) Tops Q1 EPS by 11c

STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y

May 4, 2022 4:01 PM EDT

EVO Visian® ICL Lenses Received FDA Approval and First Lenses Implanted

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 1, 2022.

First Quarter 2022 Overview

Record Net Sales of $63.2 Million Up 25% from the Prior Year Quarter ICL Sales of $58.7 Million Up 26% from the Prior Year... More